N⁶-benzoyl-2',3'-O-isopropylidene-5'-O-(triethylsilyl)adenosin-8-yl-(8->7)-N⁶-benzoyl-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]-8-iodoadenine | 328241-16-3

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: N⁶-benzoyl-2',3'-O-isopropylidene-5'-O-(triethylsilyl)adenosin-8-yl-(8->7)-N⁶-benzoyl-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]-8-iodoadenine
• 英文别名: N⁶-benzoyl-2',3'-O-isopropylidene-5'-O-(triethylsilyl)adenosin-8-yl-(8->7'-C)-N⁶-benzoyl-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]-8-iodoadenine；N-[8-[(3R)-3-[(3aR,4R,6S,6aR)-4-(6-benzamido-8-iodopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]-3-triethylsilyloxyprop-1-ynyl]-9-[(3aR,4R,6R,6aR)-2,2-dimethyl-6-(triethylsilyloxymethyl)-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]purin-6-yl]benzamide
• CAS: 328241-16-3
• 化学式: C₅₄H₆₇IN₁₀O₁₀Si₂
• 分子量: 1199.26
• InChiKey: CEKMKMLQCJOKMO-LNTFFEBCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.37
• 重原子数：
  77
• 可旋转键数：
  19
• 环数：
  10.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  219
• 氢给体数：
  2
• 氢受体数：
  16

反应信息

• 作为反应物：
  描述：

  9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]adenin-8-yl-(8->7')-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]adenine 、 N⁶-benzoyl-2',3'-O-isopropylidene-5'-O-(triethylsilyl)adenosin-8-yl-(8->7)-N⁶-benzoyl-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]-8-iodoadenine 在 tris(dibenzylideneacetone)dipalladium (0) copper(l) iodide 、 P(fur)3 作用下， 以 三乙胺 、 甲苯 为溶剂， 反应 11.0h， 以79%的产率得到
  参考文献：
  名称：

  含核碱基主链的寡核苷，第 4 部分，乙炔二基连接的腺苷四聚体的收敛合成

  摘要：

  Deprotection of the tetramer 24, obtained by coupling the iodinated dimer 18 with the alkyne 23 gave the 8',5-ethynediyl-linked adenosine-derived tetramer 27 (Scheme 3). As direct iodination of C(5')-ethynylated adenosine derivatives failed, we prepared 18 via the 8-amino derivative 17 that was available by coupling the imine 15 with the iodide 7; 15, in its turn, was obtained from the 8-chloro derivative 12 via the 4-methoxybenzylamine 14 (Scheme 2). This method for the introduction of the S-iodo substituent was worked out with the N-benzoyladenosine 1 that was transformed into the azide 2 by lithiation and treatment with tosyl azide (Scheme I). Reduction of 2 led to the amine 3 that was transformed into 7 I,3-Dipolar cycloaddition of 3 and (trimethylsilyl)acetylene gave 6. The 8-substituted derivatives 4a-d were prepared similarly to 2, but could not be transformed into 7 The known chloride 8 was transformed into the iodide 11 via the amines 9 and 10. The amines 3, 10, and 16 form more or less completely persistent intramolecular C(8)N-H . . . O(5') H-bonds, while the dimeric amine 17 forms a ca. 50% persistent H-bond. There is no UV evidence for a base-base interaction in the protected and deprotected dimers and tetramers.

  DOI：

  10.1002/1522-2675(20001220)83:12<3229::aid-hlca3229>3.0.co;2-s
• 作为产物：
  描述：

  N⁶-benzoyl-2',3'-O-isopropylidene-5'-O-(triethylsilyl)adenosin-8-yl-(8->7)-8-amino-N⁶-benzoyl-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]adenine 在 C₅H₁₁ONO 、 碘 、 potassium iodide 作用下， 以 various solvent(s) 为溶剂， 反应 0.33h， 以55%的产率得到N⁶-benzoyl-2',3'-O-isopropylidene-5'-O-(triethylsilyl)adenosin-8-yl-(8->7)-N⁶-benzoyl-9-[6,7-dideoxy-2,3-O-isopropylidene-5-O-(triethylsilyl)-β-D-allo-hept-6-ynofuranosyl]-8-iodoadenine
  参考文献：
  名称：

  含核碱基主链的寡核苷，第 4 部分，乙炔二基连接的腺苷四聚体的收敛合成

  摘要：

  Deprotection of the tetramer 24, obtained by coupling the iodinated dimer 18 with the alkyne 23 gave the 8',5-ethynediyl-linked adenosine-derived tetramer 27 (Scheme 3). As direct iodination of C(5')-ethynylated adenosine derivatives failed, we prepared 18 via the 8-amino derivative 17 that was available by coupling the imine 15 with the iodide 7; 15, in its turn, was obtained from the 8-chloro derivative 12 via the 4-methoxybenzylamine 14 (Scheme 2). This method for the introduction of the S-iodo substituent was worked out with the N-benzoyladenosine 1 that was transformed into the azide 2 by lithiation and treatment with tosyl azide (Scheme I). Reduction of 2 led to the amine 3 that was transformed into 7 I,3-Dipolar cycloaddition of 3 and (trimethylsilyl)acetylene gave 6. The 8-substituted derivatives 4a-d were prepared similarly to 2, but could not be transformed into 7 The known chloride 8 was transformed into the iodide 11 via the amines 9 and 10. The amines 3, 10, and 16 form more or less completely persistent intramolecular C(8)N-H . . . O(5') H-bonds, while the dimeric amine 17 forms a ca. 50% persistent H-bond. There is no UV evidence for a base-base interaction in the protected and deprotected dimers and tetramers.

  DOI：

  10.1002/1522-2675(20001220)83:12<3229::aid-hlca3229>3.0.co;2-s

文献信息

• Oligonucleosides with a Nucleobase-Including Backbone. Part 12
  作者：Simon Eppacher、Punit Kumar Bhardwaj、Bruno Bernet、José Luis Bravo Gala、Thomas Knöpfel、Andrea Vasella

  DOI：10.1002/hlca.200490269

  日期：2004.12

  In contradistinction to the corresponding Grignard reagent, bis[(trimethylsilyl)ethynyl]zinc reacted with the 5′-oxoadenosine 3 diastereoselectively to the β-D-allo-hept-6-ynofuranosyladenine 5. Lithiation/iodination of the monomeric propargyl alcohol 5 and of the dimeric propargyl alcohol 22 provided the 8-iodoadenosines 7 and 18, respectively, considerably shortening the synthesis of the dimeric

  在对比相应的格氏试剂，双[（三甲基甲硅烷基）乙炔基]锌与5'-oxoadenosine反应3非对映选择性的β -D-同种异体-庚-6- ynofuranosyladenine 5。单体炔丙醇5和二聚炔丙醇22的锂化/碘化分别提供了8-碘腺苷7和18，大大缩短了二聚O-甲硅烷基化的8-碘腺苷25的合成。尿苷和腺苷混合的四聚体21和32被合成了。通过线性序列制备四聚体21。Sonogashira的9和13偶联产生了三聚体16，它被C-去甲硅烷基化为17。17和19的第二次Sonogashira偶联产生了四聚体21。通过汇聚路线，将乙炔29和碘化物30偶联，以更高的产率制备四聚体32。尿苷衍生的碘化物被证明比腺苷衍生的类似物和N 6具有更高的反应活性。-未保护的腺苷衍生的炔烃比其N 6-苯甲酰化的类似物更具反应性。